ArticleJournal of experimental & clinical cancer research : CR2025
Proteoglycan-4 potentiates the antitumor efficacy of regorafenib in an orthotopic model of hepatocellular carcinoma.
Livianna Carrieri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.